| Literature DB >> 31128300 |
Galina Gabriely1, Francisco J Quintana2.
Abstract
Glioblastoma (GBM) is an aggressive and incurable brain tumor; its malignancy has been associated with the activity of tumor infiltrating myeloid cells. Myeloid cells play important roles in the tumor control by the immune response, but also in tumor progression. Indeed, GBM exploits multiple mechanisms to recruit and modulate myeloid cells. The Aryl Hydrocarbon Receptor (AHR) is a ligand activated transcription factor implicated in the regulation of myeloid cells. In this review, we will summarize current knowledge on the AHR role in the control of myeloid cells and its impact on GBM pathogenesis.Entities:
Keywords: AHR; Cancer; Glioblastoma; Immune suppression; Myeloid cells
Mesh:
Substances:
Year: 2019 PMID: 31128300 PMCID: PMC6874737 DOI: 10.1016/j.semcancer.2019.05.014
Source DB: PubMed Journal: Semin Cancer Biol ISSN: 1044-579X Impact factor: 15.707